AU2006250390B2 - 6,7-unsaturated-7-carbamoyl substituted morphinan derivative - Google Patents

6,7-unsaturated-7-carbamoyl substituted morphinan derivative Download PDF

Info

Publication number
AU2006250390B2
AU2006250390B2 AU2006250390A AU2006250390A AU2006250390B2 AU 2006250390 B2 AU2006250390 B2 AU 2006250390B2 AU 2006250390 A AU2006250390 A AU 2006250390A AU 2006250390 A AU2006250390 A AU 2006250390A AU 2006250390 B2 AU2006250390 B2 AU 2006250390B2
Authority
AU
Australia
Prior art keywords
optionally substituted
compound
chiral
lower alkyl
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006250390A
Other languages
English (en)
Other versions
AU2006250390A1 (en
Inventor
Yoshihisa Goto
Nobuhiro Haga
Shin-Ichiro Hara
Tsuyoshi Hasegawa
Masanao Inagaki
Yoshinori Tamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU2006250390A1 publication Critical patent/AU2006250390A1/en
Application granted granted Critical
Publication of AU2006250390B2 publication Critical patent/AU2006250390B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2006250390A 2005-05-25 2006-05-25 6,7-unsaturated-7-carbamoyl substituted morphinan derivative Ceased AU2006250390B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2005-151864 2005-05-25
JP2005151864 2005-05-25
JP2006-065762 2006-03-10
JP2006065762 2006-03-10
AUPCT/JP2006/310231 2006-05-23
PCT/JP2006/310231 WO2006126529A1 (ja) 2005-05-25 2006-05-23 ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体
PCT/JP2006/310454 WO2006126637A1 (ja) 2005-05-25 2006-05-25 ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体

Publications (2)

Publication Number Publication Date
AU2006250390A1 AU2006250390A1 (en) 2006-11-30
AU2006250390B2 true AU2006250390B2 (en) 2010-07-08

Family

ID=37451954

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006250390A Ceased AU2006250390B2 (en) 2005-05-25 2006-05-25 6,7-unsaturated-7-carbamoyl substituted morphinan derivative

Country Status (19)

Country Link
US (4) USRE46365E1 (enExample)
EP (1) EP1889848B8 (enExample)
JP (1) JP4323547B2 (enExample)
KR (1) KR100912782B1 (enExample)
CN (1) CN101228172B (enExample)
AU (1) AU2006250390B2 (enExample)
BR (1) BRPI0610343B8 (enExample)
CA (1) CA2609733C (enExample)
DK (1) DK1889848T3 (enExample)
ES (1) ES2525215T3 (enExample)
FR (1) FR19C1042I2 (enExample)
HU (1) HUS1900034I1 (enExample)
MX (1) MX2007014588A (enExample)
NL (1) NL300996I2 (enExample)
PL (1) PL1889848T3 (enExample)
PT (1) PT1889848E (enExample)
RU (1) RU2403255C2 (enExample)
TW (1) TWI311056B (enExample)
WO (2) WO2006126529A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006126529A1 (ja) 2005-05-25 2006-11-30 Shionogi & Co., Ltd. ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
EP2240022B1 (en) * 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Bilayered tablets comprising oxycodone and promethazine
JP5252391B2 (ja) * 2008-02-21 2013-07-31 学校法人北里研究所 オキサビシクロ［２．２．２］オクタンを有するモルヒナン誘導体およびその医薬用途
KR101660996B1 (ko) * 2008-09-16 2016-09-28 넥타르 테라퓨틱스 남용에 대한 낮은 잠재성을 갖는 페길화 오피오이드
JP5797655B2 (ja) * 2009-09-18 2015-10-21 アドラー・コーポレーション 消化管障害のためのオピオイド受容体アンタゴニストの使用
KR20130072221A (ko) * 2010-05-13 2013-07-01 주식회사 녹십자 신경보호제로서의 (+)-3-하이드록시모르피난계 다환 유도체
TWI545124B (zh) 2010-11-12 2016-08-11 鹽野義製藥股份有限公司 ６，７－不飽合－７－胺甲醯基嗎啡喃衍生物之結晶及其製造方法
EP2851075B1 (en) 2012-05-14 2021-12-01 Shionogi & Co., Ltd. Preparation containing 6,7-unsaturated-7-carbamoylmorphinan derivative
CN110325178B (zh) * 2016-12-26 2022-05-13 盐野义制药株式会社 改善含量均一性的制剂的制造方法
EP3773573A4 (en) 2018-04-12 2022-04-06 Morphic Therapeutic, Inc. ANTAGONISTS OF HUMAN INTEGRIN (ALPHA4) (BETA7)
KR102201609B1 (ko) 2019-04-19 2021-01-12 연성정밀화학(주) 날데메딘의 제조방법
RS66976B1 (sr) 2019-10-16 2025-07-31 Morphic Therapeutic Inc Inhibiranje ljudskog integrina alfa4beta7
EP4062973A4 (en) 2019-11-20 2023-11-29 Shionogi & Co., Ltd 6,7-unsaturated-7-carbamoyl morphinan derivative-containing solid formulation
CN111905111B (zh) * 2020-09-16 2023-03-31 地奥集团成都药业股份有限公司 一种评价复方谷氨酰胺组方对腹泻型肠易激综合征疗效的方法
IT202300009864A1 (it) * 2023-05-16 2024-11-16 Procos Spa Processo per la preparazione di naldemedina

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001037785A2 (en) * 1999-11-29 2001-05-31 Adolor Corporation Novel methods and compositions involving opioids and antagonists thereof
JP2004501094A (ja) * 2000-05-05 2004-01-15 ペイン・セラピューティクス・インコーポレイテッド オピオイドアゴニストの効力を増強するか、またはオピオイドアゴニストの有害な副作用を減弱するための新規な組成物および方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4272541A (en) 1978-06-02 1981-06-09 Miles Laboratories, Inc. 7,8 and 7-8 Substituted 4,5α-epoxymorphinan-6-one compounds, and methods of treating pain and drug dependence with them
US4275205A (en) 1980-05-05 1981-06-23 Miles Laboratories, Inc. 7,7-Ditosyloxymethyl-4,5α-epoxy-morphinan-6-ols
US4347361A (en) 1980-12-10 1982-08-31 Sisa, Incorporated 4,5α-Epoxy-3-hydroxy or methoxy-7-(1-hydroxy-alkyl or 1-oxoalkyl)morphinan-6-one compounds
US4370333A (en) 1981-06-29 1983-01-25 Sisa, Incorporated 17-Cyclopropylmethyl-3-hydroxy-14-methoxy 7α-methyl-morphinan-6-one and therapeutic method of treating pain with it
US4443605A (en) 1982-07-30 1984-04-17 Miles Laboratories, Inc. 7β-Arylalkyl-6α, 7 α-oxymethylene-3-methoxy or 3-hydroxy-4, 5α-epoxy-17 methyl or 17-cycloalkyl-methyl morphinans
US4440932A (en) 1982-09-09 1984-04-03 Miles Laboratories, Inc. 7β-Arylalkyl-7α-methyl-6-oxo or 6α-hydroxy-3-methoxy or 3-hydroxy-4,5α-epoxy-17-methyl or 17-cycloalkyl-methylmorphinans
US4668685A (en) * 1984-07-05 1987-05-26 E.I. Du Pont De Nemours And Company Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
NZ268969A (en) 1993-07-23 1997-06-24 Toray Industries Morphinan derivatives and pharmaceutical compositions
US5464841A (en) 1993-11-08 1995-11-07 Univ Minnesota Use of delta opioid receptor antagonists to treat immunoregulatory disorders
JP2000503019A (ja) 1996-01-10 2000-03-14 スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ 複素環縮合モルフィノイド誘導体（ｉｉ）
AU5891600A (en) 1999-07-01 2001-01-22 Chemrx Advanced Technologies, Inc. Process for synthesizing oxadiazoles
US6451806B2 (en) * 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
AU5945801A (en) 2000-05-05 2001-11-20 Pain Therapeutics Inc Opoid antagonist compositions and dosage forms
US20040024004A1 (en) 2001-05-04 2004-02-05 Sherman Barry M. Novel compositions and methods for enhancing potency or reducing adverse side effects of opioid agonists
JP4340437B2 (ja) 2000-10-31 2009-10-07 レンセラール ポリテクニック インスティチュート ８−カルボキサミド−２，６−メタノ−３−ベンズアゾシン
DE60135016D1 (de) * 2000-11-22 2008-09-04 Toray Industries Indolderivate und deren verwendung in medikamenten
ATE466016T1 (de) * 2001-08-23 2010-05-15 Organon Nv Verfahren for zur herstellung eines 14- hydroxynormorphinon-derivats
DE10161963A1 (de) 2001-12-17 2003-07-03 Johannes Schuetz 6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung
DE10229842A1 (de) * 2002-07-03 2004-02-05 Helmut Prof. Dr. Schmidhammer Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
EP1522542A1 (en) 2002-07-11 2005-04-13 Toray Industries, Inc. Therapeutic or preventive agent for nausea/vomiting
JP2006502190A (ja) 2002-09-18 2006-01-19 ザ キュレイターズ オブ ザ ユニバーシティー オブ ミズーリ デルタ−オピオイド受容体に選択的なオピエート類似物
US20040157784A1 (en) 2003-02-10 2004-08-12 Jame Fine Chemicals, Inc. Opiod tannate compositions
WO2005105093A2 (en) 2003-08-26 2005-11-10 Duke University METHOD OF ARRESTING THE SIDE EFFECTS OF µ-OPIOID RECEPTOR AGONISTS DURING THEIR ADMINISTRATION
JP5266492B2 (ja) 2004-05-28 2013-08-21 ヒューマン バイオモレキュラル リサーチ インスティテュート 代謝安定性鎮痛薬、疼痛薬物療法及び他の物質の合成
US20060063792A1 (en) 2004-09-17 2006-03-23 Adolor Corporation Substituted morphinans and methods of their use
US7142420B2 (en) 2004-09-20 2006-11-28 Qualcomm, Incorporated Devices and methods for controlling relative movement between layers of an electronic device
WO2006126529A1 (ja) 2005-05-25 2006-11-30 Shionogi & Co., Ltd. ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体
TWI545124B (zh) 2010-11-12 2016-08-11 鹽野義製藥股份有限公司 ６，７－不飽合－７－胺甲醯基嗎啡喃衍生物之結晶及其製造方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001037785A2 (en) * 1999-11-29 2001-05-31 Adolor Corporation Novel methods and compositions involving opioids and antagonists thereof
JP2003528819A (ja) * 1999-11-29 2003-09-30 アドラー コーポレーション オピオイドおよびそのアンタゴニストに関する新規方法および組成物
JP2004501094A (ja) * 2000-05-05 2004-01-15 ペイン・セラピューティクス・インコーポレイテッド オピオイドアゴニストの効力を増強するか、またはオピオイドアゴニストの有害な副作用を減弱するための新規な組成物および方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FUJII, H. et al., The First Example of the Stereoselective Synthesis of 7-(Beta)-Carbamoyl4,5-(alpha)-epoxymorphinan via a Novel and Reactive y-lactone, Chem. Pharm. Bull., 2004, VoI.52, No.6, pages 747-750 *

Also Published As

Publication number Publication date
KR100912782B1 (ko) 2009-08-18
TWI311056B (en) 2009-06-21
JP4323547B2 (ja) 2009-09-02
BRPI0610343B1 (pt) 2020-03-10
EP1889848B8 (en) 2014-12-17
NL300996I2 (nl) 2019-07-30
BRPI0610343A2 (pt) 2010-06-15
KR20080014791A (ko) 2008-02-14
US8084460B2 (en) 2011-12-27
RU2007148412A (ru) 2009-06-27
PT1889848E (pt) 2014-12-09
AU2006250390A1 (en) 2006-11-30
CA2609733A1 (en) 2006-11-30
CN101228172B (zh) 2013-04-03
NL300996I1 (nl) 2019-07-03
EP1889848B1 (en) 2014-10-15
EP1889848A1 (en) 2008-02-20
US8536192B2 (en) 2013-09-17
USRE46365E1 (en) 2017-04-11
EP1889848A4 (en) 2011-08-10
RU2403255C2 (ru) 2010-11-10
US20120135978A1 (en) 2012-05-31
WO2006126637A1 (ja) 2006-11-30
CN101228172A (zh) 2008-07-23
HUS1900034I1 (hu) 2019-07-29
USRE46375E1 (en) 2017-04-25
WO2006126529A1 (ja) 2006-11-30
DK1889848T3 (en) 2014-12-01
ES2525215T3 (es) 2014-12-19
BRPI0610343B8 (pt) 2021-05-25
CA2609733C (en) 2011-07-19
US20090203723A1 (en) 2009-08-13
MX2007014588A (es) 2008-01-24
FR19C1042I1 (enExample) 2019-08-09
TW200726470A (en) 2007-07-16
FR19C1042I2 (fr) 2020-06-19
JPWO2006126637A1 (ja) 2008-12-25
PL1889848T3 (pl) 2015-04-30

Similar Documents

Publication Publication Date Title
AU2006250390B2 (en) 6,7-unsaturated-7-carbamoyl substituted morphinan derivative
DE69321525T2 (de) Morphinan-derivate und medizinische verwendung
KR102788843B1 (ko) 스테로이드 유도체 fxr 작용체
JP5383483B2 (ja) アルツハイマー症治療用医薬組成物
US6187782B1 (en) Morphinane derivatives and medicinal use thereof
CN111655682B (zh) 一种高活性sting蛋白激动剂化合物
WO1995003308A1 (fr) Derive de morphinane et application medicale
TR201807321T4 (tr) Farnesoid x reseptörlerinin modüle edilmesi için bileşimler ve yöntemler.
JPWO1995003308A1 (ja) モルヒナン誘導体および医薬用途
JP6605157B2 (ja) デゾシンの類似体
US20200247839A1 (en) Process for preparation of sulfonylurea bile acid derivatives
TW201625655A (zh) 多烯巨環內酯衍生物
AU2006282403B2 (en) Derivative having PPAR agonistic activity
JP2019508504A (ja) 疾病の処置に有用なｃ−グリコシド化合物
EP4185590A2 (en) Mtorc1 modulators and uses thereof
US9932355B2 (en) 2,5,6,7-tetrasubstituted thiazolo[4,5-b]pyridine derivatives and use thereof
ES2912740T3 (es) Compuesto heterocíclico y aplicación del mismo en medicina
CA3152485A1 (en) Azepane derivative
EP4512797A1 (en) Chiral aryl propionic acid derivative and pharmaceutical composition thereof, and use
EP2463292A1 (en) Compound having neurite-outgrowing activity
EP4062972A1 (en) Pyrazolomorphinan derivative
KR20120108056A (ko) (ｅ)-히드록시이미노페닐아세트산 유도체의 제법
KR20090099886A (ko) 캐스파제 저해제의 프로드럭
JPH04273880A (ja) ジヒドロモルヒネ誘導体

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired